HLN

MKT CAP:$39B

Haleon plc

Market Cap

$39B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NYSE

Healthcare·Drug·🇺🇸·NYSE

Stock Price

$8.89-$0.98 (-9.92%)

Jun 8, 2026

52W High $11.1252W Low $8.61

Company Details

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The comp...

CEO

—

IPO Date

Jul 22, 2022

Website

www.haleon.com

Key Metrics TTM (GBP)

Revenue

£19.3B

+13.7% YoY

Net Income

£2.8B

EPS (Diluted)

Free Cash Flow

£2.8B

Revenue / Share

£4.30

Gross Margin

63.8%

Operating Margin

21.3%

Net Margin

14.4%

FCF Margin

14.3%

P/S

P/E

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

FY 2025

Mar 13, 2026

£10.8B-4.0%

Q4 2025

Mar 13, 2026

£5.5B-0.4%

Q2 2025

Jul 31, 2025

£5.5B-3.8%

Q1 2025

Apr 30, 2025

£2.7B-6.1%

Revenue & Profitability (GBP)

Operating Cash Flow (GBP)

CapEx Spend (GBP)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (GBP)

OpEx Breakdown (GBP)

War Chest (GBP)

Shares Outstanding

Revenue Per Employee (GBP)

Revenue / Employee